NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
The index excludes securities of issuers included in the Nasdaq-100 Index® (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100 Index® (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the NASDAQ-100 Index® based on market capitalization).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 1.62% |
| AAOI | Applied Opt | Technology | Communication Equipment | 1.25% |
| KOD | Kodiak Sciences Inc | Healthcare | Biotechnology | 1.17% |
| SGMO | Sangamo Therapeutics Inc | Healthcare | Biotechnology | 1.16% |
| CLPT | Clearpoint Neuro Inc | Healthcare | Medical Devices | 1.16% |
| THCB | Tuscan Holdings Corp | Financial Services | Shell Companies | 1.12% |
| CDXC | Chromadex Corp | Consumer Defensive | Packaged Foods | 1.09% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.05% |
| ATOM | Atomera Inc | Technology | Semiconductor Equipment & Materials | 1.05% |
| GTHX | G1 Therapeutics Inc | Healthcare | Biotechnology | 1.04% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 1.03% |
| TNDM | Tandem Diabetes Care Inc | Healthcare | Medical Devices | 1.03% |
| GERN | Geron Corporation | Healthcare | Biotechnology | 0.95% |
| GEVO | Gevo Inc | Basic Materials | Specialty Chemicals | 0.95% |
| ESPR | Esperion Therapeutics Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.94% |
| TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 0.89% |
| KURA | Kura Oncology Inc | Healthcare | Biotechnology | 0.88% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 0.84% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 0.82% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 0.82% |